Global Bone Morphogenetic Protein (BMP) 2 Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Bone Morphogenetic Protein (BMP) 2 Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

According to APO Research, The global Bone Morphogenetic Protein (BMP) 2 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering and Cellumed, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bone Morphogenetic Protein (BMP) 2, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Bone Morphogenetic Protein (BMP) 2, also provides the value of main regions and countries. Of the upcoming market potential for Bone Morphogenetic Protein (BMP) 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bone Morphogenetic Protein (BMP) 2 revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Bone Morphogenetic Protein (BMP) 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Bone Morphogenetic Protein (BMP) 2 company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Bone Morphogenetic Protein (BMP) 2 segment by Company

Medtronic
Jiuyuan Gene Engineering
Cellumed
Bone Morphogenetic Protein (BMP) 2 segment by Type

Sponge
Gel
Bone Morphogenetic Protein (BMP) 2 segment by Application

Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive Surgery
Bone Morphogenetic Protein (BMP) 2 segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Bone Morphogenetic Protein (BMP) 2 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Bone Morphogenetic Protein (BMP) 2 key companies, revenue, market share, and recent developments.
3. To split the Bone Morphogenetic Protein (BMP) 2 breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Bone Morphogenetic Protein (BMP) 2 market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bone Morphogenetic Protein (BMP) 2 significant trends, drivers, influence factors in global and regions.
6. To analyze Bone Morphogenetic Protein (BMP) 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone Morphogenetic Protein (BMP) 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bone Morphogenetic Protein (BMP) 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone Morphogenetic Protein (BMP) 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bone Morphogenetic Protein (BMP) 2 industry.
Chapter 3: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Bone Morphogenetic Protein (BMP) 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Bone Morphogenetic Protein (BMP) 2 in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Bone Morphogenetic Protein (BMP) 2 Market Size, 2019 VS 2023 VS 2030
1.3 Global Bone Morphogenetic Protein (BMP) 2 Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
2.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
2.2 Bone Morphogenetic Protein (BMP) 2 Industry Drivers
2.3 Bone Morphogenetic Protein (BMP) 2 Industry Opportunities and Challenges
2.4 Bone Morphogenetic Protein (BMP) 2 Industry Restraints
3 Bone Morphogenetic Protein (BMP) 2 Market by Company
3.1 Global Bone Morphogenetic Protein (BMP) 2 Company Revenue Ranking in 2023
3.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Company (2019-2024)
3.3 Global Bone Morphogenetic Protein (BMP) 2 Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Bone Morphogenetic Protein (BMP) 2 Company Manufacturing Base & Headquarters
3.5 Global Bone Morphogenetic Protein (BMP) 2 Company, Product Type & Application
3.6 Global Bone Morphogenetic Protein (BMP) 2 Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Bone Morphogenetic Protein (BMP) 2 Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Bone Morphogenetic Protein (BMP) 2 Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Bone Morphogenetic Protein (BMP) 2 Market by Type
4.1 Bone Morphogenetic Protein (BMP) 2 Type Introduction
4.1.1 Sponge
4.1.2 Gel
4.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type
4.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Type (2019-2030)
4.2.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type (2019-2030)
5 Bone Morphogenetic Protein (BMP) 2 Market by Application
5.1 Bone Morphogenetic Protein (BMP) 2 Application Introduction
5.1.1 Spinal Fusion
5.1.2 Trauma Surgery
5.1.3 Oral Maxillofacial Surgery
5.1.4 Reconstructive Surgery
5.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application
5.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Application (2019-2030)
5.2.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application (2019-2030)
6 Bone Morphogenetic Protein (BMP) 2 Market by Region
6.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region (2019-2030)
6.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region: 2019-2024
6.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Bone Morphogenetic Protein (BMP) 2 Sales Value (2019-2030)
6.3.2 North America Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bone Morphogenetic Protein (BMP) 2 Sales Value (2019-2030)
6.4.2 Europe Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales Value (2019-2030)
6.5.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Bone Morphogenetic Protein (BMP) 2 Sales Value (2019-2030)
6.6.2 Latin America Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales Value (2019-2030)
6.7.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Country, 2023 VS 2030
7 Bone Morphogenetic Protein (BMP) 2 Market by Country
7.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2019-2030)
7.2.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2019-2024)
7.2.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.3.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.4.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.5.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.6.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.7.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.8.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.9.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.10.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.11.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.12.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.13.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.14.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.15.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.16.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.17.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.18.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.19.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.20.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Growth Rate (2019-2030)
7.21.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Bone Morphogenetic Protein (BMP) 2 Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Medtronic
8.1.1 Medtronic Comapny Information
8.1.2 Medtronic Business Overview
8.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2019-2024)
8.1.4 Medtronic Bone Morphogenetic Protein (BMP) 2 Product Portfolio
8.1.5 Medtronic Recent Developments
8.2 Jiuyuan Gene Engineering
8.2.1 Jiuyuan Gene Engineering Comapny Information
8.2.2 Jiuyuan Gene Engineering Business Overview
8.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2019-2024)
8.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Portfolio
8.2.5 Jiuyuan Gene Engineering Recent Developments
8.3 Cellumed
8.3.1 Cellumed Comapny Information
8.3.2 Cellumed Business Overview
8.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2019-2024)
8.3.4 Cellumed Bone Morphogenetic Protein (BMP) 2 Product Portfolio
8.3.5 Cellumed Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings